Homotaurine
CAS No. 3687-18-1
Homotaurine ( Homotaurine | NC 531 | NC 758 | NSC 77071 | 3-Sulfopropylamine )
产品货号. M14268 CAS No. 3687-18-1
由于其结构与神经递质 γ-氨基丁酸 (GABA) 相似,因此具有 GABA 作用,可用作抗惊厥药。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | 获取报价 | 有现货 |
|
| 1G | ¥285 | 有现货 |
|
生物学信息
-
产品名称Homotaurine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述由于其结构与神经递质 γ-氨基丁酸 (GABA) 相似,因此具有 GABA 作用,可用作抗惊厥药。
-
产品描述Because of its similarity in structure to the neurotransmitter gamma-aminobutyric acid (GABA), it has GABAergic effects and may be useful as an anticonvulsant. Homotaurine has also been investigated as a potential treatment for Alzheimer's disease. It binds to soluble amyloid beta and inhibits the formation of neurotoxic aggregates that lead to amyloid plaque deposition in the brain. However, clinical trials failed to show improvement compared to placebo.(In Vitro):Tramiprosate (200 μg/mL, 40 μg/mL, 8 μg/mL and 1.6 μg/mL; 1 hours) significantly attenuates oxygen/glucose deprivation (OGD)- or NMDA-induced injury in NGF-differentiated PC12 cells and primary cortical neurons. Tramiprosate decreases the intensity of the association between nNOS and PSD95, and Tramiprosate also inhibits the translocation of nNOS from the cytosol to the membrane.(In Vivo):Tramiprosate (6.25-50 mg/kg; intraperitoneal injection; once) treatment dose-dependently reduces the infarct volume after MCAO. Tramiprosate (50 mg/kg) treatment shows a significant neurological functional recovery.
-
体外实验Tramiprosate (200 μg/mL, 40 μg/mL, 8 μg/mL and 1.6 μg/mL; 1 hours) significantly attenuates oxygen/glucose deprivation (OGD)- or NMDA-induced injury in NGF-differentiated PC12 cells and primary cortical neurons. Tramiprosate decreases the intensity of the association between nNOS and PSD95, and Tramiprosate also inhibits the translocation of nNOS from the cytosol to the membrane.
-
体内实验Tramiprosate (6.25-50 mg/kg; intraperitoneal injection; once) treatment dose-dependently reduces the infarct volume after MCAO. Tramiprosate (50 mg/kg) treatment shows a significant neurological functional recovery. Animal Model:Adult male Sprague-Dawley rats (200-250 g) subjected to middle cerebral artery occlusion (MCAO) Dosage:50 mg/kg, 25 mg/kg, 12.5 mg/kg or 6.25 mg/kg Administration:Intraperitoneal injection; once Result:Dose-dependently reduced the infarct volume after MCAO.
-
同义词Homotaurine | NC 531 | NC 758 | NSC 77071 | 3-Sulfopropylamine
-
通路Membrane Transporter/Ion Channel
-
靶点Beta Amyloid
-
受体Aβ| GABA
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number3687-18-1
-
分子量139.17
-
分子式C3H9NO3S
-
纯度>98% (HPLC)
-
溶解度DMSO: 10 mM
-
SMILESO=S(CCCN)(O)=O
-
化学全称3-aminopropane-1-sulfonic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
β-Amyloid 11-22
β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). AD is the most common neurodegenerative disease and afflicts about 10% of the population over 60.
-
CFMTI
CFMTI 是一种有效的选择性代谢型谷氨酸受体 (mGluR) 1 变构拮抗剂 (IC50: 2.6 nM)。
-
Amyloid β-Protein 10...
Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-secretase processing site (Lys16-Leu17 bond). It also contains the HHQK domain (residues 13-16) responsible for binding to microglial cells.
021-51111890
购物车()
sales@molnova.cn

